Finnish company develops safer polymixins
This article was originally published in Scrip
Executive Summary
Northern Antibiotics, a newly formed Finnish biotech company, has developed polymixin derivatives that combat multi-drug resistant Gram-negative bacteria and have a much lower nephrotoxicity level than other antibiotics.